Results
73,160 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Canini Elizabeth A.EVP, Chief Credit Risk Officer |  RMRegional Management Corp.Grant or award | A | — 1,275 sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Canini Elizabeth A.EVP, Chief Credit Risk Officer | RMRegional Management Corp. Grant or award | A | — 1,275 sh | Nov 4, 2026 |
| 9 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $411K 1,200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Howarth Alex G.Director |  ALTAltimmune, Inc.Grant or award | A | — 160.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Halverson EmilyVP Finance, Controller & Treas |  ALKALASKA AIR GROUP, INC.Tax withholding | F | $9,075 237 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Mewhorter Bryce LSVP & Corporate Controller |  ECLECOLAB INC.Option exercise | M | — 2,948 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Berry Jason MEVP & Chief Operating Officer | ALKALASKA AIR GROUP, INC. Option exercise | M | — 663 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Turner KamiChief Accounting Officer |  DFINDonnelley Financial Solutions, Inc.Option exercise | M | — 7,600 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | McKee Robert MichaelDirector, President & CEO |  KGSKodiak Gas Services, Inc.Open-market sale · 10b5-1 plan | SELL | $121K 2,666 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Hopman MarkChief Commercial Officer |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $6,253 370 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations |  SUPNSUPERNUS PHARMACEUTICALS, INC.Other acquisition or disposition | J | — 13.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Derivative conversion | C | $526K 24.7K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $49K 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Burchianti RalphDirector |  CBFVCB Financial Services, Inc.Option exercise | M | — | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $4,239 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Baszucki GregoryDirector |  RBLXRoblox CorpOpen-market sale · 10b5-1 plan | SELL | $204K 4,485 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Vecchio JenniferGroup President and CMO |  BURLBurlington Stores, Inc.Open-market sale · 10b5-1 plan | SELL | $132K 555 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,250 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Sensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $39K 1,219 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $526K 24.7K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 18.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Sensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Sensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Baszucki GregoryDirector | RBLXRoblox Corp Open-market sale · 10b5-1 plan | SELL | $140K 3,048 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Sensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 24.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | George Jennifer LSEVP and COO | CBFVCB Financial Services, Inc. Option exercise | M | — | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $11K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $2,603 23 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $34K 300 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.5K sh | Nov 4, 2026 traded Nov 2, 2026 |